The mode of action of levallorphan as an inhibitor of cell growth.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism*; D002247:Carbon Isotopes; D002463:Cell Membrane Permeability / Q000187:drug effects; D002499:Centrifugation, Density Gradient; D002855:Chromatography, Thin Layer; D004247:DNA / Q000096:biosynthesis*; D004926:Escherichia coli / Q000378:metabolism; D005696:Galactosidases / Q000032:analysis; D005947:Glucose / Q000378:metabolism; D006367:HeLa Cells / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D007977:Levallorphan / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism; D014498:Uracil / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D002247:Carbon Isotopes; D007977:Levallorphan; D014498:Uracil; D012313:RNA; D000255:Adenosine Triphosphate; D004247:DNA; D005696:Galactosidases; D000251:Adenosine Triphosphatases; D007930:Leucine; D005947:Glucose; D013936:Thymidine; D014529:Uridine